2011
DOI: 10.1038/nchembio.688
|View full text |Cite
|
Sign up to set email alerts
|

A natural prodrug activation mechanism in nonribosomal peptide synthesis

Abstract: We have identified a new mechanism for the cleavage and activation of nonribosomally made peptides and peptide-polyketide hybrids that are apparently operational in several different bacteria. This process includes the cleavage of a precursor molecule by a membrane-bound and D-asparagine-specific peptidase, as shown here in the biosynthesis of the antibiotic xenocoumacin from Xenorhabdus nematophila.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
144
0
5

Year Published

2012
2012
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 123 publications
(156 citation statements)
references
References 22 publications
5
144
0
5
Order By: Relevance
“…Xenocoumacin 1 is bactericidal against the producer Xenorhabdus nematophila, and X. nematophila has evolved an elegant mechanism to avoid this toxicity; an inactive prodrug, prexenocoumacin, is first biosynthesised by an NRPS, after which the active form is derived by cleavage and transport through the membrane by a dual-function membrane bound protein (Reimer et al, 2011). A further mechanism of resistance to the exported xenocoumacin 1 also exists, where X. nematophila cells that take up the compound can detoxify it through an intracellular cyclisation reaction (Reimer et al, 2011).…”
Section: Insect-associated Bacteria With Antibiotic Potentialmentioning
confidence: 99%
“…Xenocoumacin 1 is bactericidal against the producer Xenorhabdus nematophila, and X. nematophila has evolved an elegant mechanism to avoid this toxicity; an inactive prodrug, prexenocoumacin, is first biosynthesised by an NRPS, after which the active form is derived by cleavage and transport through the membrane by a dual-function membrane bound protein (Reimer et al, 2011). A further mechanism of resistance to the exported xenocoumacin 1 also exists, where X. nematophila cells that take up the compound can detoxify it through an intracellular cyclisation reaction (Reimer et al, 2011).…”
Section: Insect-associated Bacteria With Antibiotic Potentialmentioning
confidence: 99%
“…The m/z ratios observed in the different extracts are clearly in the range one would expect for the products of the identified gene clusters. Especially interesting is the hybrid PKS-NRPS gene cluster 4, encoding a compound that is most likely activated via proteolytic cleavage, as was shown for the potent antibiotic xenocoumacin from the entomopathogenic bacterium Xenorhabdus nematophila (39) and the still-unknown compound colibactin, a potent virulence factor of pathogenic Escherichia coli strains (51).…”
Section: Discussionmentioning
confidence: 99%
“…Similar NRPS have been shown to be involved in the biosynthesis of piperazines or terphenylquinones from fungi (48,49). The largest gene cluster (cluster 4) encodes an NRPS-PKS hybrid with all structural features of the prodrug activation mechanism previously identified in the biosynthesis of xenocoumacin, zwittermicin, and colibactin (39,(50)(51)(52). Additionally, a putatively incomplete NRPS-PKS hybrid gene cluster (cluster 5 in Fig.…”
Section: Artificial Rearingmentioning
confidence: 99%
See 1 more Smart Citation
“…However, HPLC/MS-based FA analysis is diffi cult, mainly because of little ionizability and hence little signal strength. Small modifi cations introduced to certain FAs, however, can greatly increase ionizability water gradient ranging from 5 to 95% in 22 min at a fl ow rate of 0.6 ml/min ( 12 ). High resolution mass spectra were obtained from a MALDI LTQ Orbitrap XL (Thermo Fisher Scientifi c, Inc., Waltham, MA) equipped with a laser at 337 nm.…”
mentioning
confidence: 99%